Table 1.
Clinical characteristics of patients.
| Characteristics | All Patients (n = 49) | Men (n = 26) | Women (n = 23) |
|---|---|---|---|
| Age (years; median, IQR) | 62.0 (56.0–70.0) | 65.0 (57.0–68.5) | 62.0 (50.5–71.5) |
| Height (cm; mean (SD) | 174 ± 8.5 | 179 ± 6.2 | 167 ± 6.4 |
| Weight (kg; mean (SD) | 80.8 ± 17.1 | 88.7 ± 15.3 | 71.9 ± 14.6 |
| BMI (kg/m2; mean ± SD) a | 26.8 ± 5.0 | 27.7 ± 4.6 | 25.7 ± 5.4 |
| Underweight (n, %) | 1 (2.0) | 0 (0.0) | 1 (4.3) |
| Normal weight (n, %) | 20 (40.8) | 9 (34.6) | 11 (47.8) |
| Overweight (n, %) | 15 (30.6) | 9 (34.6) | 6 (26.1) |
| Obesity or obese (n, %) | 13 (26.5) | 8 (30.8) | 5 (21.7) |
| Weight loss past month b | |||
| No weight loss (n, %) | 35 (71.4) | 18 (69.2) | 17 (74.0) |
| 0–5% weight loss (n, %) | 9 (18.4) | 6 (23.2) | 3 (13.0) |
| 5–10% weight loss (n, %) | 2 (4.1) | 1 (3.8) | 1 (4.3) |
| >10% weight loss (n, %) | 2 (4.1) | 1 (3.8) | 1 (4.3) |
| Missing: 1 | Missing: 1 | ||
| Weight loss past 6 months b | |||
| No weight loss (n, %) | 19 (38.8) | 8 (30.8) | 11 (47.8) |
| 0–5% weight loss (n, %) | 14 (28.6) | 9 (34.6) | 5 (21.7) |
| 5–10% weight loss (n, %) | 6 (12.2) | 3 (11.5) | 3 (13.0) |
| >10% weight loss (n, %) | 5 (10.2) | 3 (11.5) | 2 (8.7) |
| Missing: 5 | Missing: 3 | Missing: 2 | |
| Waist circumference (cm; mean ± SD) c | 99.8 ± 19.0 | 107 ± 20.1 | 91.5 ± 13.8 |
| Underweight (n, %) | 0 (0) | 0 (0) | 0 (0) |
| Healthy waist (n, %) | 13 (26.5) | 8 (30.8) | 5 (21.7) |
| Overweight (n, %) | 9 (18.4) | 3 (11.5) | 6 (26.1) |
| Obesity or obese (n, %) | 27 (55.1) | 15 (57.7) | 12 (52.2) |
| Dietary intake (mean ± SD) | |||
| Calorie intake (kcal/d) | 1950 ± 461 | 2020 ± 399 | 1880 ± 516 |
| Calorie intake (kcal/kg) | 25.6 ± 9.3 | 23.4 ± 6.6 | 27.8 ± 11.0 |
| Protein intake (gram/d) | 88.0 ± 20.1 | 92.2 ± 20.2 | 83.7 ± 19.6 |
| Protein intake (gram/kg) | 1.2 ± 0.4 | 1.1 ± 0.3 | 1.2 ± 0.4 |
| Missing: 5 | Missing: 4 | Missing: 1 | |
| PAL (median, IQR) | 1.8 (1.6–1.8) | 1.8 (1.6–1.8) | 1.8 (1.6–1.8) |
| Diagnosis (n, %) | |||
| Esophageal cancer | 24 (51) | 18 (69.2) | 6 (26) |
| Peritonitis Carcinomatosa | 25 (49) | 8 (30.8) | 17 (74) |
| Time between CT and BIA, MAMC, PG-SGA SF (days; median, IQR) | 14.0 (12.0–34.0) | 13.0 (10.3–20.4) | 19.0 (12.0–43.0) |
BMI, body mass index; PAL, physical activity level (energy expenditure); CT, computed tomography; BIA, bioelectrical impedance analysis; MAMC, mid-upper arm muscle circumference; PG-SGA SF, patient generated-subjective global assessment short form; WHO, world health organization; NHG, Dutch general practitioner society. a WHO categories: underweight BMI < 18.5, normal 18.50–24.99, overweight ≥ 25, obesity or obese ≥ 30. b According to the PG-SGA SF. c NHG categories: underweight <79 cm (m) or <68 cm (w), healthy waist 79–94 cm (m) or 68–80 cm (w), overweight 94–102 cm (m) or 80–88 cm (w), obesity or obese ≥ 102 cm (m) or ≥88 cm (w).